Forbes' Top 100 Healthcare Leaders in the Middle East!, Dr. Sherine Helmy, CEO of Pharco Pharmaceuticals

Dr. Sherine Helmy, CEO of Pharco Pharmaceuticals, has been named one of Forbes' Top 100 Healthcare Leaders in the Middle East. This recognition highlights her exceptional leadership and commitment to improving healthcare access in the region. Under her guidance, Pharco has expanded its product portfolio and established advanced manufacturing facilities, reinforcing its position in the pharmaceutical industry. Dr. Helmy's innovative strategies and advocacy for health initiatives have significantly enhanced patient outcomes. This accolade underscores her impactful contributions to the healthcare sector and her dedication to fostering a healthier future. Congratulations to Dr. Helmy on this prestigious honor!

Pharco Pharmaceuticals is proud to announce that Dr. Sherine Helmy, CEO, has been recognized as one of Forbes' Top 100 Healthcare Leaders in the Middle East. This prestigious accolade highlights her exceptional leadership and unwavering commitment to advancing healthcare in the region.

Dr. Helmy has been instrumental in driving Pharco’s mission to provide high-quality, affordable pharmaceuticals, ensuring that patients have access to essential medications. Under her guidance, the company has achieved significant milestones, including the expansion of its product portfolio and the establishment of state-of-the-art manufacturing facilities.

Her visionary approach combines innovative strategies with a deep understanding of the healthcare landscape, positioning Pharco Pharmaceuticals as a key player in the industry. Dr. Helmy is not only a trailblazer in pharmaceutical development but also a passionate advocate for health initiatives that improve patient outcomes across the Middle East.

This recognition by Forbes underscores Dr. Helmy's impact on the healthcare sector and her dedication to fostering a healthier future for all. Congratulations to Dr. Sherine Helmy on this well-deserved honor!